Neuro Vigor, a startup based in Indiana, has a new theory for what causes multiple sclerosis — and has found a generic hypertension drug that could potentially be repurposed to treat an array of neurodegenerative diseases.
MedCity News has partnered with BioCrossroads to provide coverage focused on Indiana’s next generation of growth and innovation in life sciences. Purdue spinout Neuro Vigor is developing a multiple sclerosis therapeutic that builds on the oxidative stress model of neurological disease: It’s targeting a neurotoxin that is more reactive and toxic than most free radicals, leading […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.